J.Jill(US:JILL)2025-12-10 21:36Financial Performance - Net income for the thirteen weeks ended November 1, 2025, was $9,205,000, compared to $12,348,000 for the same period in 2024, representing a decrease of approximately 25.5%[126] - Adjusted EBITDA for the thirty-nine weeks ended November 1, 2025, was $77,174,000, down from $92,642,000 in the same period in 2024, indicating a decline of about 16.7%[126] - Net sales for the thirteen weeks ended November 1, 2025, were $150,528,000, slightly lower than $151,260,000 for the same period in 2024, reflecting a decrease of approximately 0.5%[126] - Adjusted EBITDA margin for the thirteen weeks ended November 1, 2025, was 16.1%, down from 17.7% in the same period in 2024, showing a decline of 1.6 percentage points[126] - Operating income for the thirteen weeks ended November 1, 2025 was $14.9 million, a decrease of $4.3 million, or 22.4%, from $19.2 million in 2024[128] - Net income for the thirteen weeks ended November 1, 2025 was $9.2 million, down $3.1 million, or 25.5%, from $12.3 million in 2024[128] - For the thirty-nine weeks ended November 1, 2025, net sales decreased by $9.9 million, or 2.1%, to $458.1 million from $468.0 million in 2024[140] - Gross profit for the thirty-nine weeks ended November 1, 2025 decreased by $12.7 million, or 3.8%, to $322.4 million, with a gross margin of 70.4% compared to 71.6% in 2024[142] Expenses and Costs - Selling, general and administrative (SG&A) expenses increased by $3.2 million, or 3.6%, to $91.8 million, representing 61.0% of net sales compared to 58.6% in 2024[132][134] - SG&A expenses for the thirty-nine weeks ended November 1, 2025 increased by $7.4 million, or 2.8%, to $271.5 million, representing 59.3% of net sales compared to 56.4% in 2024[143][144] - Gross profit for the thirteen weeks ended November 1, 2025 decreased by $1.3 million, or 1.2%, to $106.7 million, with a gross margin of 70.9% compared to 71.4% in 2024[131] - Interest expense for the thirty-nine weeks ended November 1, 2025 was $8.2 million, a decrease of $4.8 million, or 36.8%, from $13.0 million in 2024[147] Cash Flow and Financing - Net cash provided by operating activities decreased by $13.2 million to $43.7 million for the thirty-nine weeks ended November 1, 2025, compared to $56.9 million for the same period in 2024[158][160] - Net cash used in investing activities was $8.8 million for the thirty-nine weeks ended November 1, 2025, down from $10.0 million in the prior year[161] - Net cash used in financing activities significantly decreased to $12.4 million for the thirty-nine weeks ended November 1, 2025, from $70.3 million in the same period of 2024[162] - The Company had outstanding letters of credit amounting to $4.3 million and a maximum additional borrowing capacity of $35.7 million as of November 1, 2025[156] - As of November 1, 2025, the company had $58.0 million in cash and $35.7 million of total availability under its ABL Facility[150] - The Company approved a share repurchase program authorizing the repurchase of up to $25.0 million of common stock over two years[151] - As of November 1, 2025, the Company had a remaining Term Loan Facility principal balance of $74.3 million, due on May 8, 2028[155] - The Company made voluntary prepayments of $58.2 million and $27.2 million on the Term Loan Credit Agreement in May and June 2024, respectively[154] Strategic Initiatives and Market Conditions - The ongoing implementation of strategic initiatives, including upgrades to the ecommerce platform and information systems, is expected to impact future operating results positively[110] - The company faces challenges from overall economic trends, including inflationary pressures and reduced consumer confidence, which may affect sales[107] - The retail industry remains highly competitive, with the company needing to effectively anticipate fashion trends to maintain customer appeal[109] - Changes in U.S. trade policy and tariffs may increase merchandise costs, potentially impacting gross margins in future quarters[113] - The migration of single-channel customers to omnichannel customers is significant, as omnichannel customers spend three times more on average[115] Compliance and Insurance - The Company transitioned to a self-insured group health insurance program in January 2025, with costs accrued based on known claims and estimated incurred but not reported claims[166] - The Company is in compliance with all covenants contained in its outstanding debt arrangements as of November 1, 2025[156]